Market Research Report Chemotherapy Induced Neutropenia Market Report | Page 2

in 2002. Filgrastim i.e., Neupogen and PEGylated filgrastim (Neulasta) contribute
to majority of the market size, of CIN. However, New Chemical Entities are
expected to launch in the near future. According to DelveInsight, the Global Market
size of CIN in 2016 was USD 3.67 Billion.
Table of Content:
Report Introduction
















Chemotherapy Induced Neutropenia (CIN) Market Overview at a Glance
Global Market Size of CIN in 2016
Global Market Size of CIN in 2023
Chemotherapy Induced Neutropenia (CIN)
Overview
Causes of Neutropenia
Common cycle of chemotherapy-related neutropenia
Signs and symptoms
Risk Factors
Severity and Grades of Neutropenia
Pathophysiology/ Mechanisms of action
Diagnosis
Epidemiology and Patient Population
Assumptions and Caveats
United States
Incident Cases of ten major Cancer indications in United States
Read Full Report with TOC:
http://www.marketresearchhub.com/report/chemotherapy-induced-neutropenia-
cin-market-insights-epidemiology-and-market-forecast2023-report.html
Buy Report Now!